| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH11 HSP90B2P MYO1D MYO1E TDRD9 MYO7B PSMC2 SRP54 SPO11 DDX10 DDX46 ABCD1 KIF2C IPO8 DDX52 CCT7 CHD7 SMC2 CCT6A | 6.76e-06 | 614 | 190 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 6.61e-05 | 227 | 190 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B2P MYO1E TDRD9 PSMC2 SRP54 DDX10 DDX46 ABCD1 KIF2C DDX52 CCT7 CHD7 SMC2 CCT6A | 8.79e-05 | 441 | 190 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 9.01e-05 | 2 | 190 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 2.69e-04 | 3 | 190 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | D1 dopamine receptor binding | 2.86e-04 | 14 | 190 | 3 | GO:0031748 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 3.69e-04 | 36 | 190 | 4 | GO:0015035 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.55e-04 | 38 | 190 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 6.58e-04 | 73 | 190 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | actin binding | MYH11 MYO1D MYO1E MYO7B DST FSCN2 TLN2 XIRP2 P4HB MICAL2 FHOD1 CTNNA1 TNNC1 | 7.01e-04 | 479 | 190 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 7.33e-04 | 43 | 190 | 4 | GO:0015036 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAB39 EPS15 CALML5 DYSF RYR2 BMP1 DST PNLIPRP2 PCDHAC2 OCM2 DLL1 PPP2R3A PPP3R1 OCM SLC25A13 UNC13C TNNC1 | 8.38e-04 | 749 | 190 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase regulator activity | 8.84e-04 | 5 | 190 | 2 | GO:0008597 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CAB39 RGPD1 CALML5 EVI5 DFFA SERPINA1 SERPINI2 ARFGAP3 CAB39L GNAS HERC1 PLXNB1 RABIF COL6A3 ADRM1 RAPGEF4 OCRL CCNF DNAJA3 WDR91 PPP2R3A PPP3R1 RASGEF1C ARHGAP28 RCAN2 NCKAP1L | 9.68e-04 | 1418 | 190 | 26 | GO:0030234 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSP90B2P MYO1E TDRD9 PSMC2 SRP54 DDX10 DDX46 ABCD1 GNAS KIF2C RAB17 DDX52 DUT CCT7 CHD7 RAB14 SMC2 CCT6A | 1.12e-03 | 839 | 190 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSP90B2P MYO1E TDRD9 PSMC2 SRP54 DDX10 DDX46 ABCD1 GNAS KIF2C RAB17 DDX52 DUT CCT7 CHD7 RAB14 SMC2 CCT6A | 1.14e-03 | 840 | 190 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSP90B2P MYO1E TDRD9 PSMC2 SRP54 DDX10 DDX46 ABCD1 GNAS KIF2C RAB17 DDX52 DUT CCT7 CHD7 RAB14 SMC2 CCT6A | 1.14e-03 | 840 | 190 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.14e-03 | 22 | 190 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.14e-03 | 22 | 190 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.14e-03 | 22 | 190 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSP90B2P MYO1E TDRD9 PSMC2 SRP54 DDX10 DDX46 ABCD1 GNAS KIF2C RAB17 DDX52 CCT7 CHD7 RAB14 SMC2 CCT6A | 1.21e-03 | 775 | 190 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | beta-glucosidase activity | 1.32e-03 | 6 | 190 | 2 | GO:0008422 | |
| GeneOntologyBiologicalProcess | intracellular transport | CCDC91 GPRASP1 EPS15 MYO1D RGPD1 SRP54 NUP205 EVI5 DST GRK3 ARFGAP3 CLN5 USP7 ABCD1 GNAS TRAPPC11 RAB17 IPO8 BAG3 RAB14 SDAD1 HPS3 WDR91 PPP3R1 P4HB FHOD1 UHMK1 ALYREF NUP93 TNNC1 SNX5 | 1.93e-05 | 1496 | 191 | 31 | GO:0046907 |
| GeneOntologyBiologicalProcess | protein folding | HSP90B2P RGPD1 DFFA PDILT PDIA2 AGR2 BAG3 CCT7 DNAJA3 CCT6A P4HB | 1.94e-05 | 246 | 191 | 11 | GO:0006457 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYH11 MYO1D MYO1E MYO7B CLIC5 PIK3CB FSCN2 ANPEP RAPGEF4 OCM2 LCT SLC2A2 SHANK2 OCM SNX5 | 2.09e-09 | 223 | 190 | 15 | GO:0098862 |
| GeneOntologyCellularComponent | brush border | MYH11 MYO1D MYO1E MYO7B PIK3CB ANPEP RAPGEF4 LCT SLC2A2 SHANK2 SNX5 | 1.49e-07 | 152 | 190 | 11 | GO:0005903 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 MYO1D MYO1E MYO7B DST CLIC5 FSCN2 TLN2 BAG3 OCM2 DNAJA3 OCM XIRP2 MICAL2 FHOD1 CTNNA1 TNNC1 | 2.16e-05 | 576 | 190 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | CAB39 CYP2A13 SPAG4 MYH11 DYSF RYR2 KRT76 DST GRK3 KIF2C COL6A1 CACNA1S COL6A3 CLASP1 TPPP2 BAG3 DVL1 CCT7 OCM2 DNAJA3 CCT6A SHANK2 OCM XIRP2 MICAL2 TNNC1 | 2.56e-05 | 1179 | 190 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CAB39 CYP2A13 SPAG4 MYH11 DYSF RYR2 KRT76 DST GRK3 KIF2C COL6A1 CACNA1S COL6A3 CLASP1 TPPP2 BAG3 DVL1 CCT7 OCM2 DNAJA3 CCT6A SHANK2 OCM XIRP2 MICAL2 TNNC1 | 2.87e-05 | 1187 | 190 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | cuticular plate | 1.98e-04 | 13 | 190 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 2.45e-04 | 3 | 190 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 2.45e-04 | 3 | 190 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.35e-04 | 290 | 190 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcolemma | 3.57e-04 | 190 | 190 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 8.01e-04 | 46 | 190 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | I band | 8.26e-04 | 166 | 190 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 9.12e-04 | 273 | 190 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | elongator holoenzyme complex | 1.20e-03 | 6 | 190 | 2 | GO:0033588 | |
| MousePheno | no spontaneous movement | 1.42e-05 | 123 | 164 | 9 | MP:0001404 | |
| Domain | - | CLIC5 GPX6 PDILT PDIA2 SH3BGR SH3BGRL AGR2 GPX3 GPX5 NXN P4HB | 4.75e-08 | 122 | 190 | 11 | 3.40.30.10 |
| Domain | Thioredoxin-like_fold | CLIC5 GPX6 PDILT PDIA2 SH3BGR SH3BGRL AGR2 GPX3 GPX5 NXN P4HB | 1.07e-07 | 132 | 190 | 11 | IPR012336 |
| Domain | EF-hand-dom_pair | EPS15 SPEF2 EFCAB13 CALML5 RYR2 DST SCN7A CACNA1S TPPP2 OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 2.59e-07 | 287 | 190 | 15 | IPR011992 |
| Domain | ARM-type_fold | CAB39 GPRASP1 NCAPG2 PIK3CB PI4KA PDS5A CAB39L IPO8 CLASP1 APOB ARMCX5 SDAD1 FHOD1 PUM1 | 1.02e-05 | 339 | 190 | 14 | IPR016024 |
| Domain | Parvalbumin | 1.02e-05 | 5 | 190 | 3 | IPR008080 | |
| Domain | EF-hand_7 | 2.55e-05 | 85 | 190 | 7 | PF13499 | |
| Domain | EF_HAND_2 | EPS15 EFCAB13 CALML5 RYR2 DST OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 2.55e-05 | 231 | 190 | 11 | PS50222 |
| Domain | EF-hand_1 | 2.59e-05 | 152 | 190 | 9 | PF00036 | |
| Domain | GPX_AS | 3.52e-05 | 7 | 190 | 3 | IPR029759 | |
| Domain | EFh | 3.52e-05 | 158 | 190 | 9 | SM00054 | |
| Domain | EF_HAND_1 | EPS15 EFCAB13 CALML5 DST OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 4.68e-05 | 204 | 190 | 10 | PS00018 |
| Domain | GLUTATHIONE_PEROXID_2 | 5.59e-05 | 8 | 190 | 3 | PS00763 | |
| Domain | GLUTATHIONE_PEROXID_1 | 5.59e-05 | 8 | 190 | 3 | PS00460 | |
| Domain | Glutathione_peroxidase | 5.59e-05 | 8 | 190 | 3 | IPR000889 | |
| Domain | GLUTATHIONE_PEROXID_3 | 5.59e-05 | 8 | 190 | 3 | PS51355 | |
| Domain | GPX_CS | 5.59e-05 | 8 | 190 | 3 | IPR029760 | |
| Domain | GSHPx | 5.59e-05 | 8 | 190 | 3 | PF00255 | |
| Domain | - | EPS15 EFCAB13 CALML5 RYR2 DST OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 7.73e-05 | 261 | 190 | 11 | 1.10.238.10 |
| Domain | - | CAB39 GPRASP1 NCAPG2 PDS5A CAB39L IPO8 CLASP1 ARMCX5 FHOD1 PUM1 | 9.50e-05 | 222 | 190 | 10 | 1.25.10.10 |
| Domain | Mo25 | 1.03e-04 | 2 | 190 | 2 | IPR013878 | |
| Domain | PGLYCERATE_KINASE | 1.03e-04 | 2 | 190 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 1.03e-04 | 2 | 190 | 2 | IPR015824 | |
| Domain | Mo25 | 1.03e-04 | 2 | 190 | 2 | PF08569 | |
| Domain | - | 1.03e-04 | 2 | 190 | 2 | 3.40.50.1270 | |
| Domain | - | 1.03e-04 | 2 | 190 | 2 | 3.40.50.1260 | |
| Domain | PGK | 1.03e-04 | 2 | 190 | 2 | PF00162 | |
| Domain | Phosphoglycerate_kinase_CS | 1.03e-04 | 2 | 190 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 1.03e-04 | 2 | 190 | 2 | IPR015901 | |
| Domain | DVL-1 | 1.03e-04 | 2 | 190 | 2 | IPR008340 | |
| Domain | THIOREDOXIN_1 | 1.11e-04 | 25 | 190 | 4 | PS00194 | |
| Domain | EF_hand_dom | EPS15 CALML5 RYR2 DST OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 1.36e-04 | 232 | 190 | 10 | IPR002048 |
| Domain | Phosphoglycerate_kinase | 3.07e-04 | 3 | 190 | 2 | IPR001576 | |
| Domain | IQ_motif_EF-hand-BS | 3.14e-04 | 90 | 190 | 6 | IPR000048 | |
| Domain | EF_Hand_1_Ca_BS | 4.33e-04 | 175 | 190 | 8 | IPR018247 | |
| Domain | ARM-like | CAB39 GPRASP1 NCAPG2 PDS5A CAB39L IPO8 CLASP1 ARMCX5 FHOD1 PUM1 | 4.59e-04 | 270 | 190 | 10 | IPR011989 |
| Domain | Myosin_head_motor_dom | 5.84e-04 | 38 | 190 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.84e-04 | 38 | 190 | 4 | PS51456 | |
| Domain | Myosin_head | 5.84e-04 | 38 | 190 | 4 | PF00063 | |
| Domain | MYSc | 5.84e-04 | 38 | 190 | 4 | SM00242 | |
| Domain | Dishevelled | 6.09e-04 | 4 | 190 | 2 | PF02377 | |
| Domain | Glut_rich_SH3-bd | 6.09e-04 | 4 | 190 | 2 | IPR006993 | |
| Domain | Glyco_hydro_1_N_CS | 6.09e-04 | 4 | 190 | 2 | IPR033132 | |
| Domain | SH3BGR | 6.09e-04 | 4 | 190 | 2 | PF04908 | |
| Domain | Glyco_hydro_1_AS | 6.09e-04 | 4 | 190 | 2 | IPR018120 | |
| Domain | Dishevelled_fam | 6.09e-04 | 4 | 190 | 2 | IPR008339 | |
| Domain | Prot_disulphide_isomerase | 6.09e-04 | 4 | 190 | 2 | IPR005792 | |
| Domain | Dishevelled_protein_dom | 6.09e-04 | 4 | 190 | 2 | IPR003351 | |
| Domain | Thioredoxin_domain | 7.83e-04 | 41 | 190 | 4 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 9.39e-04 | 43 | 190 | 4 | PS51352 | |
| Domain | GLYCOSYL_HYDROL_F1_1 | 1.01e-03 | 5 | 190 | 2 | PS00572 | |
| Domain | Glyco_hydro_1 | 1.01e-03 | 5 | 190 | 2 | PF00232 | |
| Domain | GLYCOSYL_HYDROL_F1_2 | 1.01e-03 | 5 | 190 | 2 | PS00653 | |
| Domain | Glyco_hydro_1 | 1.01e-03 | 5 | 190 | 2 | IPR001360 | |
| Domain | P-loop_NTPase | MYH11 MYO1D MYO1E TDRD9 MYO7B SPEF2 PSMC2 SRP54 DDX10 DDX46 ABCD1 GNAS KIF2C RAB17 DDX52 CHD7 RAB14 SMC2 NLRP9 | 1.07e-03 | 848 | 190 | 19 | IPR027417 |
| Domain | DEP | 1.38e-03 | 22 | 190 | 3 | PF00610 | |
| Domain | DEP | 1.38e-03 | 22 | 190 | 3 | PS50186 | |
| Domain | DEP | 1.38e-03 | 22 | 190 | 3 | SM00049 | |
| Domain | IQ | 1.42e-03 | 81 | 190 | 5 | SM00015 | |
| Domain | DEP_dom | 1.58e-03 | 23 | 190 | 3 | IPR000591 | |
| Domain | Vinculin/catenin | 2.09e-03 | 7 | 190 | 2 | IPR006077 | |
| Domain | Myosin_TH1 | 2.09e-03 | 7 | 190 | 2 | PF06017 | |
| Domain | DIX | 2.09e-03 | 7 | 190 | 2 | PF00778 | |
| Domain | Myosin_TH1 | 2.09e-03 | 7 | 190 | 2 | IPR010926 | |
| Domain | DIX | 2.09e-03 | 7 | 190 | 2 | IPR001158 | |
| Domain | TH1 | 2.09e-03 | 7 | 190 | 2 | PS51757 | |
| Domain | DIX | 2.09e-03 | 7 | 190 | 2 | PS50841 | |
| Domain | DAX | 2.09e-03 | 7 | 190 | 2 | SM00021 | |
| Domain | IPT | 2.53e-03 | 27 | 190 | 3 | SM00429 | |
| Domain | IQ | 2.61e-03 | 93 | 190 | 5 | PS50096 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYO1D NACA SREK1 CALML5 PGK1 NUP205 DDX10 DFFA PMPCA RBM19 PI4KA SF3A3 USP7 PDS5A TLN2 GNAS SYNCRIP IPO8 HSDL2 DDX52 DUT ELP1 CCT7 RPSA APOB SMC2 SYAP1 SDAD1 DNAJA3 CCT6A P4HB PA2G4 SLC25A13 MRPS9 ALYREF NUP93 PUM1 | 4.75e-15 | 1425 | 194 | 37 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NACA PSMC2 SRP54 NCAPG2 PGK1 NUP205 DDX10 DST SGPL1 RBM19 PI4KA SF3A3 USP7 PDS5A KIF2C SYNCRIP DDX52 BAG3 ELP1 CCT7 RPSA CHD7 OCRL SMC2 DNAJA3 CCT6A P4HB PA2G4 MICAL2 FHOD1 SLC25A13 ALYREF NUP93 PUM1 | 1.80e-13 | 1353 | 194 | 34 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO1D MYO1E NACA PGK1 NUP205 DST SGPL1 RBM19 SF3A3 USP7 GNAS KIF2C SYNCRIP ADRM1 DDX52 CCT7 RPSA RAB14 SMC2 SDAD1 DNAJA3 CCT6A P4HB PA2G4 FHOD1 SLC25A13 MRPS9 ALYREF CTNNA1 NUP93 LSM14B | 3.88e-12 | 1257 | 194 | 31 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D NACA PGK1 NUP205 DDX10 DDX46 DST ZC3H4 PI4KA SF3A3 GNAS SYNCRIP DDX52 ELP1 CCT7 RPSA RAB14 SMC2 CCT6A P4HB PA2G4 SLC25A13 ALYREF CTNNA1 NUP93 PUM1 | 1.35e-10 | 1024 | 194 | 26 | 24711643 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSP90B2P PSMC2 NCAPG2 NUP205 SERPINA1 PTPRD PMPCA PTPRS SF3A3 GNAS KIF2C SYNCRIP IPO8 CLASP1 ADRM1 BAG3 ELP1 CCT7 RAB14 SMC2 P4HB PRKAB1 ALYREF CTNNA1 NUP93 | 2.53e-10 | 974 | 194 | 25 | 28675297 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPS15 NACA PSMC2 PGK1 DDX46 DST ZC3H4 SF3A3 USP7 PDS5A GNAS SYNCRIP ADRM1 BAG3 CCT7 RPSA RAB14 SMC2 SYAP1 DNAJA3 CCT6A P4HB PA2G4 ALYREF NUP93 LSM14B SNX5 | 3.18e-10 | 1149 | 194 | 27 | 35446349 |
| Pubmed | MYO1D PSMC2 SRP54 NUP205 PMPCA SF3A3 USP7 GNAS SYNCRIP IPO8 HSDL2 ADRM1 DDX52 DUT ELP1 CCT7 RPSA NXN SDAD1 DNAJA3 CCT6A P4HB WDR87 SLC25A13 MRPS9 ALYREF CTNNA1 NUP93 LSM14B | 4.06e-10 | 1335 | 194 | 29 | 29229926 | |
| Pubmed | CAB39 MYH11 HSP90B2P MYO1D MYO1E NCAM2 PGK1 KRT76 DST PTPRS SGPL1 PI4KA USP7 TLN2 SYNCRIP CLASP1 RAPGEF4 ELP1 CCT7 RPSA GRIN2A RAB14 CCT6A CRYM SHANK2 P4HB MICAL2 MRPS9 LRRCC1 CTNNA1 | 4.52e-10 | 1431 | 194 | 30 | 37142655 | |
| Pubmed | CYP2A13 MYH11 MYO1D SPEF2 RGPD1 MYNN SREK1 PGK1 PGK2 RYR2 NUP205 KRT76 NRXN3 DST PMPCA PDIA2 KDR PLXNA2 SYNCRIP BBOF1 DDX52 APOB RAB14 SMC2 CCT6A SHANK2 PHF20L1 P4HB SLC25A13 MRPS9 | 5.42e-10 | 1442 | 194 | 30 | 35575683 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CAB39 MYO1D PSMC2 SREK1 CALML5 NUP205 DFFA PTPRS CLN5 SF3A3 USP7 PDS5A CHST12 CAB39L GNAS HERC1 SYNCRIP RAB17 CLASP1 RAB14 SMC2 NXN SDAD1 P4HB PA2G4 PRKAB1 MRPS9 NUP93 | 7.72e-10 | 1284 | 194 | 28 | 17353931 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | PSMC2 SRP54 SREK1 DDX46 MED12L SF3A3 TLN2 GNAS KIF2C SYNCRIP CLASP1 ELP1 CCT7 CHD7 SMC2 CCT6A FHOD1 CTNNA1 NUP93 | 8.56e-10 | 582 | 194 | 19 | 20467437 |
| Pubmed | MYO1D PSMC2 PGK1 NUP205 DDX10 DDX46 DST USP7 PDS5A SYNCRIP DDX52 ELP1 RPSA CHD7 P4HB SLC25A13 ALYREF CTNNA1 NUP93 PUM1 | 9.04e-10 | 653 | 194 | 20 | 22586326 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYO1E NACA PSMC2 PGK1 DDX46 ZC3H4 RBM19 SF3A3 USP7 PDS5A SYNCRIP CLASP1 HSDL2 BAG3 DUT ELP1 CCT7 RPSA RAB14 SMC2 DNAJA3 CCT6A P4HB PA2G4 FHOD1 SLC25A13 MRPS9 ALYREF CTNNA1 | 1.53e-09 | 1415 | 194 | 29 | 28515276 |
| Pubmed | NACA PSMC2 SH3GLB2 NUP205 PI4KA ALG5 SF3A3 USP7 ABCD1 KIF2C IPO8 HSDL2 ADRM1 CCT7 APOB CCT6A P4HB PA2G4 SLC25A13 NUP93 PUM1 | 1.82e-09 | 754 | 194 | 21 | 35906200 | |
| Pubmed | MYO1E NACA PSMC2 CALML5 NCAPG2 NUP205 EVI5 DDX46 DST SGPL1 ALG5 SF3A3 USP7 PDS5A GNAS SYNCRIP IPO8 DUT ELP1 CCT7 SMC2 SDAD1 CCT6A PA2G4 SLC25A13 MRPS9 ALYREF CTNNA1 NUP93 | 2.27e-09 | 1440 | 194 | 29 | 30833792 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CAB39 HSP90B2P NACA PSMC2 PGK1 NUP205 KRT76 SGPL1 PI4KA KIF2C RPSA RAB14 DNAJA3 CCT6A PPP3R1 GUCY2C FHOD1 NUP93 | 3.46e-09 | 564 | 194 | 18 | 21565611 |
| Pubmed | CAB39 PSMC2 SH3GLB2 PGK1 NUP205 DFFA KRT76 USP7 CAB39L TRAPPC11 CCT7 XIRP2 P4HB PA2G4 PRKAB1 NUP93 | 3.90e-09 | 437 | 194 | 16 | 20562859 | |
| Pubmed | NACA PSMC2 SRP54 ZC3H4 SGPL1 USP7 PDS5A GNAS SYNCRIP IPO8 ADRM1 BAG3 CCT7 RPSA SMC2 DNAJA3 CCT6A PA2G4 MRPS9 ALYREF UNC13C LSM14B NCKAP1L | 6.30e-09 | 971 | 194 | 23 | 33306668 | |
| Pubmed | NCOA6 MYO1D NACA RGPD1 PSMC2 GIGYF1 CALML5 NUP205 DDX10 IRF9 DST USP7 PDS5A HERC1 SYNCRIP ADRM1 DDX52 CCT7 RPSA CHD7 SDAD1 CCT6A P4HB SLC25A13 MRPS9 NUP93 LSM14B PUM1 | 7.99e-09 | 1429 | 194 | 28 | 35140242 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TTC14 PSMC2 SREK1 CALML5 NUP205 DDX10 ZC3H4 RBM19 SF3A3 USP7 KIF2C SYNCRIP DDX52 BAG3 DUT RPSA RAB14 SDAD1 CCT6A P4HB SLC25A13 MRPS9 ALYREF | 8.86e-09 | 989 | 194 | 23 | 36424410 |
| Pubmed | MYO1E NACA PSMC2 NUP205 DDX46 USP7 SYNCRIP HSDL2 CCT7 RPSA RAB14 NXN SDAD1 DNAJA3 P4HB SLC25A13 MRPS9 ALYREF CTNNA1 | 2.17e-08 | 711 | 194 | 19 | 33022573 | |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 2.70e-08 | 161 | 194 | 10 | 36398662 | |
| Pubmed | NACA PSMC2 EZH1 PGK1 ABCD1 GNAS SYNCRIP SH3BGRL BAG3 DUT CCT7 RPSA RAB14 SMC2 CCT6A P4HB PA2G4 SLC25A13 ALYREF NUP93 | 2.89e-08 | 803 | 194 | 20 | 36517590 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | EPS15 NACA RGPD1 PGK1 STN1 FANCB SERPINA1 DDX46 ZC3H4 SF3A3 PDS5A TLN2 GNAS SYNCRIP IPO8 ANPEP CLASP1 CCT7 PHF20L1 P4HB PA2G4 ALYREF CTNNA1 NUP93 | 3.49e-08 | 1155 | 194 | 24 | 20360068 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CAB39 MYH11 MYO1D GALNT7 DYSF PGK1 PGK2 SERPINA1 KL KRT76 SERPINI2 PTPRD PTPRS CLN5 GNAS COL6A1 COL6A3 ANPEP GPX3 APOB CCT6A CRYM MMRN2 | 3.74e-08 | 1070 | 194 | 23 | 23533145 |
| Pubmed | EPS15 DST PTPRD PI4KA SF3A3 GNAS CLASP1 DDX52 EBF1 DLL1 CRYM ARHGAP28 CTNNA1 | 3.78e-08 | 322 | 194 | 13 | 26514267 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPS15 NACA SH3GLB2 SRP54 SREK1 PGK1 NUP205 DDX46 RBM19 SF3A3 GNAS KIF2C IPO8 CLASP1 ADRM1 BAG3 CCT7 RPSA RAB14 SMC2 CCT6A P4HB PA2G4 ALYREF CTNNA1 NUP93 | 5.21e-08 | 1367 | 194 | 26 | 32687490 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 PSMC2 GALNT7 NCAPG2 NUP205 DDX10 PI4KA ALG5 PDS5A ABCD1 HSDL2 ADRM1 DDX52 BAG3 ELP1 OCRL RAB14 PA2G4 CTNNA1 NUP93 PUM1 | 8.34e-08 | 942 | 194 | 21 | 31073040 |
| Pubmed | GPRASP1 HSP90B2P NACA RGPD1 PSMC2 PGK1 RYR2 ARFGAP3 PI4KA USP7 TLN2 ADRM1 SH3BGRL DVL1 CCT7 RPSA GRIN2A DNAJA3 CCT6A SHANK2 PPP3R1 P4HB MRPS9 | 1.15e-07 | 1139 | 194 | 23 | 36417873 | |
| Pubmed | MYO1D PSMC2 PTPRD PMPCA PTPRS PI4KA USP7 HERC1 HSDL2 BAG3 ELP1 CCT7 SDAD1 DNAJA3 PPP2R3A PPP3R1 P4HB ROBO1 CTNNA1 NUP93 PUM1 GAB1 | 1.16e-07 | 1049 | 194 | 22 | 27880917 | |
| Pubmed | GPRASP1 EPS15 RGPD1 PGK1 DST PTPRD PTPRS ZC3H4 PI4KA TLN2 KIF2C CLASP1 RAPGEF4 CHD7 GRIN2A RAB14 SMC2 WDR91 SHANK2 ALYREF CTNNA1 | 1.20e-07 | 963 | 194 | 21 | 28671696 | |
| Pubmed | PSMC2 NUP205 DDX46 USP7 PDS5A SYNCRIP IPO8 DDX52 ELP1 CCT7 RPSA SMC2 CCT6A P4HB SLC25A13 NUP93 PUM1 | 1.29e-07 | 638 | 194 | 17 | 33239621 | |
| Pubmed | NACA PSMC2 PGK1 SF3A3 USP7 PDS5A SYNCRIP ADRM1 CCT7 RPSA CCT6A P4HB PA2G4 CTNNA1 NUP93 | 1.40e-07 | 494 | 194 | 15 | 26831064 | |
| Pubmed | MYH11 NACA PSMC2 SRP54 CALML5 PGK1 KRT76 DDX46 SF3A3 SYNCRIP DUT CCT7 RPSA CHD7 RAB14 SMC2 CYTIP CCT6A P4HB SLC25A13 MRPS9 ALYREF LSM14B | 1.42e-07 | 1153 | 194 | 23 | 29845934 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SREK1 DYSF SERPINA1 DDX46 ZC3H4 USP7 HERC1 KIF2C CLASP1 RAPGEF4 SDAD1 XIRP2 SLC25A13 CTNNA1 PUM1 | 1.51e-07 | 497 | 194 | 15 | 36774506 |
| Pubmed | NACA CALML5 DDX10 DDX46 ZC3H4 SF3A3 TLN2 SYNCRIP DDX52 CCT7 RPSA SMC2 DNAJA3 CCT6A P4HB PA2G4 ALYREF LSM14B | 1.75e-07 | 731 | 194 | 18 | 29298432 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPS15 PDE3A MYO1E NACA PSMC2 SH3GLB2 ELP6 NUP205 DFFA SF3A3 USP7 HERC1 SYNCRIP CACNA1S ADRM1 BAG3 DUT ELP1 CCT7 RPSA SMC2 CCT6A P4HB PA2G4 CTNNA1 SNX5 | 1.76e-07 | 1455 | 194 | 26 | 22863883 |
| Pubmed | NACA CALML5 PGK1 NUP205 FANCB SERPINA1 SF3A3 PDS5A GNAS SYNCRIP RPSA APOB RAB14 SMC2 P4HB ALYREF NUP93 | 1.76e-07 | 652 | 194 | 17 | 31180492 | |
| Pubmed | EPS15 PSMC2 GALNT7 NCAPG2 PGK1 NUP205 ARFGAP3 RBM19 PI4KA ALG5 CHST12 ABCD1 GNAS KIF2C SYNCRIP CLASP1 HSDL2 DDX52 RPSA PA2G4 FHOD1 NUP93 NCKAP1L | 1.79e-07 | 1168 | 194 | 23 | 19946888 | |
| Pubmed | 2.98e-07 | 208 | 194 | 10 | 22145905 | ||
| Pubmed | EPS15 NACA SRP54 SREK1 DDX10 DDX46 DST ARFGAP3 SGPL1 RBM19 PI4KA USP7 PDS5A KIF2C CLASP1 DDX52 CCT7 RPSA CHD7 SDAD1 CCT6A SHANK2 P4HB PA2G4 SLC25A13 LSM14B | 3.03e-07 | 1497 | 194 | 26 | 31527615 | |
| Pubmed | EPS15 MYH11 MYO1D PSMC2 KRT76 PIK3CB ELP1 CCT7 DNAJA3 CCT6A GAB1 | 3.41e-07 | 266 | 194 | 11 | 19380743 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NACA PSMC2 SREK1 NUP205 DDX10 DDX46 ALG5 SF3A3 KIF2C SYNCRIP HSDL2 DDX52 RPSA CHD7 RAB14 SMC2 DNAJA3 CCT6A CELF2 PA2G4 SLC25A13 MRPS9 NUP93 PUM1 | 3.90e-07 | 1318 | 194 | 24 | 30463901 |
| Pubmed | EPS15 PGK1 RYR2 DST ZC3H4 ARFGAP3 RBM19 PI4KA PDS5A CCT7 APOB OCRL RAB14 CCT6A PPP2R3A MRPS9 ROBO1 GAB1 | 4.25e-07 | 777 | 194 | 18 | 35844135 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | NCOA6 MYH11 HSP90B2P PSMC2 DST SF3A3 GNAS SYNCRIP CCT7 RPSA GRIN2A RAB14 SMC2 CCT6A SLC25A13 NUP93 | 4.80e-07 | 621 | 194 | 16 | 22794259 |
| Pubmed | NCOA6 NACA CALML5 DST ZC3H4 USP7 TLN2 CLASP1 HSDL2 SMC2 SDAD1 FHOD1 ALYREF LSM14B | 4.89e-07 | 472 | 194 | 14 | 38943005 | |
| Pubmed | NACA ELP6 NUP205 DST SGPL1 USP7 GNAS DDX52 DNAJA3 CCT6A FHOD1 SLC25A13 MRPS9 NUP93 LSM14B | 5.09e-07 | 547 | 194 | 15 | 37267103 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | PSMC2 SH3GLB2 SRP54 PGK1 PMPCA CLN5 SF3A3 SYNCRIP CCT7 RPSA NXN SYAP1 CCT6A P4HB PA2G4 LSM14B SNX5 | 5.11e-07 | 704 | 194 | 17 | 32994395 |
| Pubmed | NCOA6 MYO1D PSMC2 PGK1 USP7 GNAS SYNCRIP DDX52 AGR2 BAG3 DVL1 CCT7 RPSA SMC2 CCT6A P4HB PA2G4 MICAL2 WDR87 SLC25A13 ALYREF CTNNA1 NUP93 | 5.58e-07 | 1247 | 194 | 23 | 27684187 | |
| Pubmed | NACA PSMC2 PGK1 ZC3H4 SF3A3 KIF2C SYNCRIP IPO8 CCT7 RPSA CCT6A P4HB PA2G4 ALYREF LSM14B | 5.58e-07 | 551 | 194 | 15 | 34728620 | |
| Pubmed | CAB39 CALML5 EZH1 DST SGPL1 PI4KA USP7 PDS5A SYNCRIP RPSA DNAJA3 PA2G4 MICAL2 SLC25A13 CTNNA1 SNX5 | 6.30e-07 | 634 | 194 | 16 | 34591612 | |
| Pubmed | Novel missense MTTP gene mutations causing abetalipoproteinemia. | 6.81e-07 | 4 | 194 | 3 | 25108285 | |
| Pubmed | MYH11 MYO1D PSMC2 CALML5 PGK1 ABCD1 GNAS SYNCRIP CCT7 DNAJA3 P4HB SLC25A13 PUM1 | 7.48e-07 | 418 | 194 | 13 | 35338135 | |
| Pubmed | MYH11 MYO1E NACA SRP54 PGK1 NUP205 DDX10 DDX46 RBM19 GNAS RAB17 CLASP1 DDX52 PCDHAC2 ELP1 APOB CHD7 RAB14 SDAD1 P4HB PA2G4 ALYREF NUP93 LSM14B | 7.85e-07 | 1371 | 194 | 24 | 36244648 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYO1D PSMC2 SH3GLB2 SRP54 DST PMPCA ZC3H4 ARFGAP3 PI4KA GNAS HERC1 KIF2C SYNCRIP IPO8 HSDL2 DVL1 ELP1 CCT7 OCRL SYAP1 DNAJA3 CCT6A SLC25A13 MRPS9 ALYREF | 1.05e-06 | 1496 | 194 | 25 | 32877691 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 NACA PSMC2 SRP54 CALML5 PGK1 DDX10 DDX46 DST ZC3H4 USP7 BAG3 DUT CCT7 RPSA OCRL SYAP1 PA2G4 FHOD1 | 1.39e-06 | 934 | 194 | 19 | 33916271 |
| Pubmed | NACA PSMC2 PGK1 DDX46 SF3A3 USP7 SYNCRIP ADRM1 AGR2 CCT7 DNAJA3 CCT6A | 1.58e-06 | 377 | 194 | 12 | 25147182 | |
| Pubmed | 1.67e-06 | 101 | 194 | 7 | 18519826 | ||
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 1.69e-06 | 5 | 194 | 3 | 21477648 | |
| Pubmed | The expanded collagen VI family: new chains and new questions. | 1.69e-06 | 5 | 194 | 3 | 23869615 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH11 MYO1E NACA DDX10 DDX46 DST USP7 GNAS KIF2C SYNCRIP DDX52 CCT7 RPSA APOB CCT6A SLC25A13 ALYREF CTNNA1 NUP93 | 1.76e-06 | 949 | 194 | 19 | 36574265 |
| Pubmed | MYO1D PSMC2 NUP205 SYNCRIP IPO8 CCT7 RPSA SMC2 DNAJA3 CCT6A SLC25A13 NUP93 | 1.86e-06 | 383 | 194 | 12 | 29331416 | |
| Pubmed | PSMC2 FBXW2 NUP205 PTPRS SYNCRIP COL6A1 HSDL2 CCT7 SMC2 CCT6A P4HB SLC25A13 ALYREF NUP93 PUM1 | 2.08e-06 | 613 | 194 | 15 | 22268729 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HSP90B2P MYO1D RGPD1 SGPL1 ADRM1 ELP1 CCT7 RPSA SMC2 SDAD1 DNAJA3 PA2G4 SLC25A13 MRPS9 ALYREF NUP93 | 2.31e-06 | 701 | 194 | 16 | 30196744 |
| Pubmed | NACA PSMC2 PGK1 NUP205 SYNCRIP IPO8 CCT7 CCT6A P4HB PA2G4 SLC25A13 ALYREF NUP93 | 2.31e-06 | 463 | 194 | 13 | 34901782 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD1 PSMC2 NCAPG2 NUP205 PMPCA USP7 GNAS SYNCRIP HSDL2 ADRM1 ELP1 CCT7 RPSA RAB14 SMC2 DNAJA3 CCT6A P4HB PA2G4 SLC25A13 NUP93 PUM1 | 2.35e-06 | 1257 | 194 | 22 | 37317656 |
| Pubmed | EPS15 NACA PGK1 NUP205 CLIC5 PI4KA SF3A3 KIF2C SYNCRIP CCT7 RPSA CCT6A CELF2 PA2G4 ALYREF NUP93 | 2.58e-06 | 707 | 194 | 16 | 19738201 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MYO1E PGK1 USP7 PDS5A SYNCRIP AGR2 RPSA NXN DNAJA3 PA2G4 FHOD1 CTNNA1 | 2.91e-06 | 400 | 194 | 12 | 35013556 |
| Pubmed | 2.95e-06 | 110 | 194 | 7 | 25940091 | ||
| Pubmed | CAB39 MYO1D DST GNAS CCT7 DNAJA3 CCT6A P4HB SLC25A13 PRKAB1 ALYREF CTNNA1 | 2.99e-06 | 401 | 194 | 12 | 25852190 | |
| Pubmed | Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. | 3.14e-06 | 111 | 194 | 7 | 32683582 | |
| Pubmed | 3.21e-06 | 72 | 194 | 6 | 36376293 | ||
| Pubmed | NACA PSMC2 SRP54 SREK1 USP7 KIF2C SYNCRIP HSDL2 DUT CCT7 RPSA SMC2 CCT6A P4HB PA2G4 ALYREF CTNNA1 | 3.35e-06 | 809 | 194 | 17 | 32129710 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | NACA ALG5 SYNCRIP CCT7 RPSA DNAJA3 CCT6A P4HB PA2G4 SLC25A13 ALYREF CTNNA1 LSM14B | 3.43e-06 | 480 | 194 | 13 | 25437307 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | NACA STN1 DDX46 ZC3H4 SGPL1 USP7 SYNCRIP DDX52 SMC2 DNAJA3 SLC25A13 MRPS9 ALYREF | 3.92e-06 | 486 | 194 | 13 | 30940648 |
| Pubmed | 4.24e-06 | 20 | 194 | 4 | 21689717 | ||
| Pubmed | 4.61e-06 | 166 | 194 | 8 | 34687317 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | PSMC2 PGK1 NUP205 HERC1 IPO8 ELP1 CCT7 DNAJA3 CCT6A PPP2R3A P4HB PA2G4 SLC25A13 NUP93 | 4.69e-06 | 573 | 194 | 14 | 28330616 |
| Pubmed | CAB39 SH3GLB2 DYSF DST CLIC5 MED12L COL6A3 ELP1 DNAJA3 CCT6A XIRP2 P4HB SNX5 | 4.99e-06 | 497 | 194 | 13 | 23414517 | |
| Pubmed | Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. | 5.13e-06 | 78 | 194 | 6 | 16236267 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MYO1E GIGYF1 NCAPG2 NUP205 FANCB ARFGAP3 SF3A3 KIF2C SYNCRIP IPO8 CLASP1 HSDL2 ADRM1 BAG3 OCRL RAB14 SMC2 NXN P4HB PA2G4 ALYREF CTNNA1 | 5.19e-06 | 1321 | 194 | 22 | 27173435 |
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 5.88e-06 | 7 | 194 | 3 | 18276594 | |
| Pubmed | HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. | 5.88e-06 | 7 | 194 | 3 | 15910762 | |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 11368344 | ||
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 5.88e-06 | 7 | 194 | 3 | 18400749 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.20e-06 | 123 | 194 | 7 | 26912792 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | EPS15 ADCY2 EVI5 KRT76 PTPRD PIK3CB ABCD1 HERC1 PLXNA2 RAB17 ELP1 CHD7 GRIN2A OCM2 NXN OCM TET1 PRKAB1 APOL4 CSMD1 SNX5 | 6.86e-06 | 1242 | 194 | 21 | 30973865 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | NACA SREK1 CALML5 RBM19 SYNCRIP DDX52 BAG3 CCT7 RPSA SDAD1 DNAJA3 CCT6A SLC25A13 MRPS9 ALYREF | 7.01e-06 | 678 | 194 | 15 | 30209976 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | SRP54 PGK1 NUP205 SERPINA1 DDX46 SF3A3 USP7 BAG3 RAB14 P4HB PA2G4 SLC25A13 CTNNA1 NUP93 | 8.99e-06 | 607 | 194 | 14 | 39147351 |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 37591863 | ||
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 10652368 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 9.38e-06 | 8 | 194 | 3 | 24563484 | |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 19643732 | ||
| Pubmed | 9.43e-06 | 183 | 194 | 8 | 23956138 | ||
| Pubmed | NCOA6 NACA SH3GLB2 NUP205 DDX46 NRXN3 DST ZC3H4 MED12L PLXNB1 NPEPL1 TET1 NUP93 | 9.71e-06 | 529 | 194 | 13 | 14621295 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRP54 SREK1 NUP205 DDX46 DST ZC3H4 SF3A3 USP7 PDS5A PLXNB1 SYNCRIP CLASP1 RPSA CHD7 SDAD1 DNAJA3 CCT6A P4HB SLC25A13 | 1.14e-05 | 1082 | 194 | 19 | 38697112 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.16e-05 | 313 | 194 | 10 | 38270169 | |
| Pubmed | NACA PSMC2 PGK1 DDX46 DST PI4KA CAB39L CCT7 RPSA SMC2 CCT6A PPP3R1 PA2G4 | 1.16e-05 | 538 | 194 | 13 | 28524877 | |
| Pubmed | 1.17e-05 | 248 | 194 | 9 | 32963011 | ||
| Pubmed | EPS15 PSMC2 DST PDS5A KIF2C SYNCRIP CCT7 OCRL SMC2 SYAP1 CCT6A SLC25A13 ROBO1 CTNNA1 GAB1 | 1.17e-05 | 708 | 194 | 15 | 39231216 | |
| Interaction | BIRC3 interactions | MYO1D NACA CALML5 PGK1 NUP205 DDX10 DFFA PMPCA RBM19 SF3A3 USP7 PDS5A TLN2 GNAS SYNCRIP IPO8 HSDL2 DDX52 DUT CCT7 RPSA APOB SMC2 SYAP1 DNAJA3 CCT6A P4HB PA2G4 SLC25A13 MRPS9 ALYREF NUP93 PUM1 | 5.09e-07 | 1334 | 194 | 33 | int:BIRC3 |
| Interaction | MAPK6 interactions | PSMC2 CALML5 GALNT7 SERPINA1 DST ARFGAP3 GNAS HSDL2 ADRM1 ELP1 CCT7 OCRL ARMCX5 SYAP1 DNAJA3 CCT6A SLC25A13 PRKAB1 | 8.20e-07 | 474 | 194 | 18 | int:MAPK6 |
| Interaction | CDC5L interactions | TTC14 PSMC2 SRP54 SREK1 DDX46 DST MED12L SF3A3 USP7 TLN2 GNAS KIF2C SYNCRIP CLASP1 ELP1 CCT7 SMC2 SDAD1 CCNF CCT6A FHOD1 ALYREF CTNNA1 NUP93 | 2.63e-06 | 855 | 194 | 24 | int:CDC5L |
| Interaction | CCDC8 interactions | MYO1D NACA NUP205 DST PI4KA GNAS SYNCRIP ELP1 CCT7 APOB RAB14 SMC2 CCNF CCT6A P4HB PA2G4 SLC25A13 CTNNA1 NUP93 PUM1 | 5.71e-06 | 656 | 194 | 20 | int:CCDC8 |
| Interaction | MTNR1B interactions | 6.49e-06 | 135 | 194 | 9 | int:MTNR1B | |
| Interaction | PSMB8 interactions | 8.02e-06 | 105 | 194 | 8 | int:PSMB8 | |
| Interaction | EPB41L4A interactions | 8.72e-06 | 140 | 194 | 9 | int:EPB41L4A | |
| Interaction | SUMO4 interactions | 1.94e-05 | 86 | 194 | 7 | int:SUMO4 | |
| Interaction | WDR5 interactions | NCOA6 MYO1E NACA PSMC2 NUP205 DDX46 USP7 KIF2C SYNCRIP HSDL2 ADRM1 CCT7 RPSA CHD7 RAB14 NXN SDAD1 CCNF DNAJA3 CCT6A PHF20L1 P4HB SLC25A13 MRPS9 ALYREF CTNNA1 | 2.14e-05 | 1101 | 194 | 26 | int:WDR5 |
| Interaction | RAD21 interactions | NACA PSMC2 CALML5 PGK1 BMP1 SF3A3 PDS5A RABIF SYNCRIP CCT7 APOB SMC2 XIRP2 ALYREF | 2.24e-05 | 384 | 194 | 14 | int:RAD21 |
| Interaction | CIT interactions | GPRASP1 MYH11 HSP90B2P MYO1E NACA SRP54 SREK1 NUP205 DDX10 DDX46 PIK3CB RBM19 SF3A3 PDS5A GNAS HERC1 KIF2C SYNCRIP CLASP1 RPSA APOB DNAJA3 CCT6A NLRP9 P4HB PA2G4 SLC25A13 PRKAB1 ALYREF CTNNA1 NUP93 | 2.26e-05 | 1450 | 194 | 31 | int:CIT |
| Interaction | PSMA3 interactions | PSMC2 SH3GLB2 ELP6 PGK1 SF3A3 USP7 ADRM1 AGR2 BAG3 DVL1 CCT7 RPSA CCNF CCT6A P4HB | 2.69e-05 | 443 | 194 | 15 | int:PSMA3 |
| Interaction | METTL14 interactions | NACA PSMC2 EVI5 DDX46 PMPCA SF3A3 USP7 GNAS HERC1 SYNCRIP COL6A3 DUT CCT7 RPSA CCT6A P4HB ALYREF | 2.99e-05 | 558 | 194 | 17 | int:METTL14 |
| Interaction | SIRT7 interactions | MYO1D PSMC2 PGK1 NUP205 DDX10 DDX46 DST USP7 PDS5A SYNCRIP DDX52 ELP1 RPSA CHD7 P4HB SLC25A13 ALYREF CTNNA1 NUP93 PUM1 | 3.51e-05 | 744 | 194 | 20 | int:SIRT7 |
| Interaction | STIP1 interactions | PSMC2 SH3GLB2 PGK1 NUP205 DDX46 PI4KA USP7 PDS5A SYNCRIP IPO8 DDX52 AGR2 DUT ELP1 CCT7 RPSA SMC2 CCNF CCT6A P4HB SLC25A13 CTNNA1 NUP93 PUM1 | 3.88e-05 | 1006 | 194 | 24 | int:STIP1 |
| Interaction | ATG16L1 interactions | MYO1D PSMC2 CCDC168 GIGYF1 RYR2 SGPL1 HERC1 PLXNA2 IPO8 ADRM1 DVL1 ELP1 CCT7 RPSA OCRL SMC2 SDAD1 DNAJA3 PPP2R3A PA2G4 SLC25A13 MRPS9 ROBO1 ALYREF CTNNA1 NUP93 | 5.22e-05 | 1161 | 194 | 26 | int:ATG16L1 |
| Interaction | FZR1 interactions | GPRASP1 NACA PSMC2 SRP54 ZC3H4 SGPL1 USP7 PDS5A GNAS SYNCRIP IPO8 CLASP1 ADRM1 BAG3 CCT7 RPSA SMC2 CCNF DNAJA3 CCT6A PA2G4 MRPS9 ALYREF UNC13C LSM14B NCKAP1L | 6.10e-05 | 1172 | 194 | 26 | int:FZR1 |
| Interaction | KCTD13 interactions | CAB39 GPRASP1 MYH11 MYO1D MYO1E NCAM2 PGK1 DST PTPRS SGPL1 PI4KA USP7 TLN2 SYNCRIP CLASP1 RAPGEF4 ELP1 CCT7 RPSA GRIN2A RAB14 CCT6A CRYM SHANK2 P4HB MICAL2 MRPS9 LRRCC1 CTNNA1 | 7.00e-05 | 1394 | 194 | 29 | int:KCTD13 |
| Interaction | FBXO22 interactions | SREK1 DYSF SERPINA1 DDX46 ZC3H4 USP7 HERC1 KIF2C CLASP1 RAPGEF4 SDAD1 CCNF XIRP2 SLC25A13 CTNNA1 PUM1 | 7.16e-05 | 540 | 194 | 16 | int:FBXO22 |
| Interaction | ANXA5 interactions | 7.30e-05 | 227 | 194 | 10 | int:ANXA5 | |
| Interaction | B3GNT2 interactions | PDE3A MYH11 MYO1D PSMC2 CALML5 GALNT7 PGK1 ABCD1 GNAS SYNCRIP CCT7 SMC2 DNAJA3 P4HB SLC25A13 PUM1 | 7.48e-05 | 542 | 194 | 16 | int:B3GNT2 |
| Interaction | RECQL4 interactions | MYO1D PSMC2 SRP54 NUP205 PMPCA SF3A3 USP7 GNAS SYNCRIP IPO8 HSDL2 ADRM1 DDX52 DUT ELP1 CCT7 RPSA NXN SDAD1 DNAJA3 CCT6A P4HB WDR87 SLC25A13 MRPS9 ALYREF CTNNA1 NUP93 LSM14B | 8.77e-05 | 1412 | 194 | 29 | int:RECQL4 |
| Interaction | GPX6 interactions | 9.22e-05 | 2 | 194 | 2 | int:GPX6 | |
| Interaction | LRRK2 interactions | MYO1D NACA STN1 DFFA PIK3CB USP7 ADRM1 BAG3 RAPGEF4 DVL1 RPSA PHF20L1 XIRP2 P4HB PA2G4 | 9.66e-05 | 496 | 194 | 15 | int:LRRK2 |
| Interaction | ASXL1 interactions | PSMC2 SF3A3 DUT CCT7 APOB DNAJA3 CCT6A P4HB PA2G4 SLC25A13 NUP93 | 1.08e-04 | 286 | 194 | 11 | int:ASXL1 |
| Interaction | LAMTOR5 interactions | 1.20e-04 | 153 | 194 | 8 | int:LAMTOR5 | |
| Interaction | FOXL1 interactions | 1.23e-04 | 196 | 194 | 9 | int:FOXL1 | |
| Interaction | RPA4 interactions | EPS15 NACA PSMC2 SRP54 PGK1 SERPINA1 DST SF3A3 SYNCRIP IPO8 ADRM1 DVL1 SYAP1 CCT6A | 1.29e-04 | 452 | 194 | 14 | int:RPA4 |
| Interaction | EED interactions | MYH11 MYO1D MYO1E PSMC2 EZH1 PGK1 NUP205 DDX10 SGPL1 RBM19 SF3A3 USP7 PDS5A KIF2C SYNCRIP DDX52 ELP1 CCT7 RPSA CHD7 RAB14 SMC2 NXN CCT6A XIRP2 SLC25A13 ALYREF CTNNA1 NUP93 | 1.31e-04 | 1445 | 194 | 29 | int:EED |
| Interaction | KLHL33 interactions | 1.42e-04 | 28 | 194 | 4 | int:KLHL33 | |
| Interaction | BRD7 interactions | NACA RGPD1 STN1 DDX46 ZC3H4 SGPL1 USP7 SYNCRIP DDX52 AGR2 DVL1 CHD7 SMC2 DNAJA3 SLC25A13 MRPS9 ALYREF | 1.51e-04 | 637 | 194 | 17 | int:BRD7 |
| Interaction | BAP1 interactions | EPS15 NACA PSMC2 PGK1 DDX46 DST ZC3H4 SF3A3 USP7 PDS5A GNAS SYNCRIP ADRM1 BAG3 CCT7 RPSA RAB14 SMC2 SYAP1 DNAJA3 CCT6A P4HB PA2G4 ALYREF NUP93 LSM14B SNX5 | 1.56e-04 | 1314 | 194 | 27 | int:BAP1 |
| Interaction | RAB1B interactions | 1.78e-04 | 253 | 194 | 10 | int:RAB1B | |
| Interaction | DDI2 interactions | 2.00e-04 | 124 | 194 | 7 | int:DDI2 | |
| Interaction | AGO2 interactions | NCOA6 PSMC2 GIGYF1 DFFA DDX46 SYNCRIP IPO8 SH3BGR AGR2 CCNF P4HB FHOD1 LSM14B PUM1 | 2.02e-04 | 472 | 194 | 14 | int:AGO2 |
| GeneFamily | EF-hand domain containing | EPS15 EFCAB13 CALML5 RYR2 DST OCM2 PPP2R3A PPP3R1 OCM SLC25A13 TNNC1 | 6.15e-07 | 219 | 132 | 11 | 863 |
| GeneFamily | Protein disulfide isomerases | 1.48e-05 | 21 | 132 | 4 | 692 | |
| GeneFamily | Elongator acetyltransferase complex | 7.78e-04 | 6 | 132 | 2 | 539 | |
| GeneFamily | Myosins, class I | 1.44e-03 | 8 | 132 | 2 | 1097 | |
| GeneFamily | Plexins | 1.84e-03 | 9 | 132 | 2 | 683 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | MYH11 PGK1 DDX10 KL DST CLIC5 PTPRD KDR ANPEP SH3BGR GPX3 PPP2R3A CRYM SHANK2 SLC25A13 CTNNA1 PUM1 | 8.08e-07 | 553 | 193 | 17 | M1475 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 6.97e-06 | 177 | 193 | 9 | M39245 | |
| Coexpression | IBRAHIM_NRF1_UP | NACA DDX10 RBM19 SF3A3 ABCD1 SYNCRIP BAG3 GPX3 CCT7 RAB14 SYAP1 CCT6A SP140 | 1.55e-05 | 420 | 193 | 13 | M42509 |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 1.71e-05 | 198 | 193 | 9 | M5591 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP | 1.85e-05 | 200 | 193 | 9 | M9447 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.85e-05 | 200 | 193 | 9 | M8614 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 1.85e-05 | 200 | 193 | 9 | M8836 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 1.85e-05 | 200 | 193 | 9 | M6254 | |
| Coexpression | GSE3982_MAC_VS_BCELL_UP | 1.85e-05 | 200 | 193 | 9 | M5494 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.04e-05 | 155 | 193 | 8 | M39246 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.25e-05 | 126 | 193 | 7 | M39132 | |
| Coexpression | CHEN_LUNG_CANCER_SURVIVAL | 5.08e-05 | 28 | 193 | 4 | M8526 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NACA PSMC2 PGK1 NUP205 DDX10 KRT76 DDX46 PMPCA PDS5A KIF2C SYNCRIP DDX52 DUT SMC2 LCT CCNF PA2G4 | 5.19e-05 | 761 | 193 | 17 | M11961 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 | CAB39 EPS15 NCAM2 CALML5 GALNT7 ARFGAP3 CAB39L SH3BGRL AGR2 SHANK2 PHF20L1 FHOD1 GAB1 | 7.69e-05 | 491 | 193 | 13 | M13661 |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 7.89e-05 | 96 | 193 | 6 | M5910 | |
| Coexpression | YANG_BREAST_CANCER_ESR1_LASER_UP | 8.72e-05 | 32 | 193 | 4 | M10541 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.05e-04 | 250 | 193 | 9 | M11318 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP | 1.07e-04 | 196 | 193 | 8 | M4999 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.07e-04 | 196 | 193 | 8 | M41105 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 1.15e-04 | 198 | 193 | 8 | M3242 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 1.19e-04 | 199 | 193 | 8 | M4607 | |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.24e-04 | 200 | 193 | 8 | M300 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN | 1.24e-04 | 200 | 193 | 8 | M3880 | |
| Coexpression | HAN_SATB1_TARGETS_DN | SPAG4 DYSF DST ABCD1 RABIF WNT7A AGR2 DVL1 SHANK2 FHOD1 RCAN2 | 1.53e-04 | 388 | 193 | 11 | M15491 |
| Coexpression | NGO_MALIGNANT_GLIOMA_1P_LOH | 1.68e-04 | 15 | 193 | 3 | M19965 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.69e-04 | 157 | 193 | 7 | M9117 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | FBXW2 MYNN EZH1 GALNT7 KL DST CLIC5 GPX6 SCN7A MED12L SYNCRIP RAB17 CHD7 RAB14 SMC2 DLL1 SLC2A2 CRYM PPP3R1 UHMK1 ZNF518B TNNC1 | 3.30e-06 | 795 | 192 | 22 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | MYO1D ELP6 FBXW2 MYNN EZH1 KL CLIC5 PTPRD SCN7A MED12L USP7 KDR CHD7 SMC2 DLL1 NPEPL1 SLC2A2 CRYM FHOD1 UHMK1 MMRN2 | 2.43e-05 | 837 | 192 | 21 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TTC14 MYNN RYR2 PTPRS USP7 PLXNA2 IPO8 RAPGEF4 SMC2 UHMK1 ARHGAP28 ZNF518B PUM1 | 5.14e-05 | 385 | 192 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NCOA6 TTC14 FBXW2 SREK1 DDX10 EVI5 SERPINA1 DDX46 NRXN3 CLIC5 USP7 PDS5A KIF2C IPO8 CLASP1 SH3BGRL WNT7A AGR2 CHD7 RAB14 SMC2 CRYM SHANK2 OCM SLC25A13 TET1 LRRCC1 ALYREF ZNF518B | 5.16e-05 | 1459 | 192 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | NCAM2 COL6A5 RYR2 PTPRS SCN7A COL6A1 COL6A3 GPX3 FHOD1 ROBO1 ARHGAP28 | 6.76e-10 | 187 | 194 | 11 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | NCAM2 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 ROBO1 ARHGAP28 UNC13C | 9.45e-10 | 193 | 194 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | NCAM2 RYR2 DST PTPRS SCN7A CAB39L COL6A1 COL6A3 EBF1 ROBO1 ARHGAP28 | 1.05e-09 | 195 | 194 | 11 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDE3A NCAM2 RYR2 DST PTPRS SCN7A TLN2 COL6A1 COL6A3 EBF1 ARHGAP28 | 1.11e-09 | 196 | 194 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NCAM2 RYR2 DST PTPRS SCN7A CAB39L COL6A1 COL6A3 EBF1 ROBO1 ARHGAP28 | 1.11e-09 | 196 | 194 | 11 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 COL6A5 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.17e-09 | 197 | 194 | 11 | 13896ec65ccda0b928c91d41112dc01b480036b7 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | PDE3A NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 EBF1 ROBO1 ARHGAP28 | 1.17e-09 | 197 | 194 | 11 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | PDE3A NCAM2 RYR2 PTPRS SCN7A COL6A1 COL6A3 GPX3 EBF1 ROBO1 ARHGAP28 | 1.24e-09 | 198 | 194 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | NCAM2 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 GPX3 ROBO1 ARHGAP28 | 1.24e-09 | 198 | 194 | 11 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | NCAM2 COL6A5 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 ROBO1 ARHGAP28 | 1.24e-09 | 198 | 194 | 11 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | PDE3A NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 EBF1 ROBO1 ARHGAP28 | 1.31e-09 | 199 | 194 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 EBF1 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | NCAM2 COL6A5 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | NCAM2 COL6A5 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 EBF1 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 RYR2 DST PTPRS SCN7A CAB39L COL6A1 COL6A3 GPX3 ROBO1 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 EBF1 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NCAM2 COL6A5 RYR2 DST PTPRD PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.38e-09 | 200 | 194 | 11 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 7.51e-09 | 181 | 194 | 10 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-09 | 184 | 194 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-09 | 184 | 194 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-09 | 184 | 194 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.19e-08 | 190 | 194 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | NCAM2 PTPRD SCN7A COL6A1 COL6A3 GPX3 EBF1 CELF2 SLC25A13 ROBO1 | 1.19e-08 | 190 | 194 | 10 | 12992ec80a7b4f4f17de693f0719ee061a9918fd |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NCAM2 RYR2 DST PTPRS SCN7A CAB39L COL6A1 COL6A3 ROBO1 ARHGAP28 | 1.26e-08 | 191 | 194 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NCAM2 RYR2 DST PTPRS SCN7A CAB39L COL6A1 COL6A3 ROBO1 ARHGAP28 | 1.32e-08 | 192 | 194 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 ROBO1 ARHGAP28 | 1.39e-08 | 193 | 194 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | RYR2 DST PTPRS SCN7A TLN2 CAB39L COL6A1 COL6A3 GPX3 ARHGAP28 | 1.46e-08 | 194 | 194 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.53e-08 | 195 | 194 | 10 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 COL6A5 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.53e-08 | 195 | 194 | 10 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | NCAM2 COL6A5 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 ROBO1 ARHGAP28 | 1.53e-08 | 195 | 194 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 COL6A5 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 GPX3 ARHGAP28 | 1.53e-08 | 195 | 194 | 10 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-08 | 196 | 194 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-08 | 196 | 194 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-08 | 198 | 194 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 RYR2 DST PTPRS SCN7A COL6A1 COL6A3 EBF1 ROBO1 ARHGAP28 | 1.95e-08 | 200 | 194 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CCDC91 MYO1E DST SERPINI2 CLIC5 PTPRD SCN7A CACNA1S ARHGAP28 | 5.60e-08 | 168 | 194 | 9 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-08 | 177 | 194 | 9 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-08 | 177 | 194 | 9 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.40e-07 | 187 | 194 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.40e-07 | 187 | 194 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.47e-07 | 188 | 194 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.53e-07 | 189 | 194 | 9 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 190 | 194 | 9 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 190 | 194 | 9 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-07 | 191 | 194 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.68e-07 | 191 | 194 | 9 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.68e-07 | 191 | 194 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.75e-07 | 192 | 194 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.83e-07 | 193 | 194 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.83e-07 | 193 | 194 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-07 | 193 | 194 | 9 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-07 | 194 | 194 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.91e-07 | 194 | 194 | 9 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-07 | 194 | 194 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.00e-07 | 195 | 194 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.00e-07 | 195 | 194 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-07 | 196 | 194 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-07 | 196 | 194 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-07 | 197 | 194 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.18e-07 | 197 | 194 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-07 | 198 | 194 | 9 | a76366611f3561fc8aca7d62d1f0a0ea2bef7792 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-07 | 199 | 194 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-07 | 199 | 194 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.48e-07 | 200 | 194 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-07 | 200 | 194 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-07 | 154 | 194 | 8 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 158 | 194 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 158 | 194 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 170 | 194 | 8 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 170 | 194 | 8 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 170 | 194 | 8 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.23e-06 | 179 | 194 | 8 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-06 | 181 | 194 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 181 | 194 | 8 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 181 | 194 | 8 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-06 | 182 | 194 | 8 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.51e-06 | 184 | 194 | 8 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 185 | 194 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 185 | 194 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.71e-06 | 187 | 194 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.78e-06 | 188 | 194 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 189 | 194 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 189 | 194 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 190 | 194 | 8 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-06 | 190 | 194 | 8 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 190 | 194 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 190 | 194 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.00e-06 | 191 | 194 | 8 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 192 | 194 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 192 | 194 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 192 | 194 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.08e-06 | 192 | 194 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 193 | 194 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 193 | 194 | 8 | 19dfc4a2c91fcea4f5991e7c44df46faeecb06b8 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 193 | 194 | 8 | 351e0acd411a9eb0dbc0e358d0d1e3759753fa40 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 193 | 194 | 8 | 8be24713f8ba2545b7647d1994e9e993623ddaa3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 193 | 194 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 193 | 194 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| Disease | vital capacity | CCDC91 NCOA6 PDE3A MYO1E RYR2 STN1 SERPINA1 DST CLIC5 PTPRD KDR CAB39L SDR16C5 CACNA1S COL6A3 IPO8 SLC2A9 WNT7A APOB CHD7 GRIN2A EBF1 LCT GAB1 | 1.39e-06 | 1236 | 189 | 24 | EFO_0004312 |
| Disease | cancer (implicated_via_orthology) | 9.78e-06 | 268 | 189 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | CCDC91 NCOA6 SPAG4 EFCAB13 RGPD1 DYSF DCST1 SERPINA1 NRXN3 PMPCA ZC3H4 GPX6 SF3A3 HERC1 SDR16C5 DUT GPX5 APOB GRIN2A NUP93 | 3.09e-05 | 1106 | 189 | 20 | EFO_0021796 |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | forced expiratory volume | CCDC91 NCOA6 TDRD9 CHRNA3 RYR2 STN1 SERPINA1 NRXN3 DST KDR IPO8 WNT7A GRIN2A EBF1 RASGEF1C GAB1 | 5.29e-05 | 789 | 189 | 16 | EFO_0004314 |
| Disease | Manic Disorder | 9.45e-05 | 71 | 189 | 5 | C0024713 | |
| Disease | response to anti-tuberculosis drug, drug-induced liver injury | 1.22e-04 | 3 | 189 | 2 | EFO_0004228, EFO_0007918 | |
| Disease | susceptibility to mumps measurement | 1.23e-04 | 75 | 189 | 5 | EFO_0008404 | |
| Disease | Manic | 1.48e-04 | 78 | 189 | 5 | C0338831 | |
| Disease | Depression, Bipolar | 1.57e-04 | 79 | 189 | 5 | C0005587 | |
| Disease | telomere length | 2.00e-04 | 313 | 189 | 9 | EFO_0004505 | |
| Disease | Malignant neoplasm of breast | NCOA6 EFCAB13 DYSF DDX10 BMP1 KRT76 PTPRD PIK3CB ARFGAP3 KDR PLXNB1 AGR2 ELP1 DLL1 SLC2A2 NLRP9 ROBO1 GAB1 | 2.01e-04 | 1074 | 189 | 18 | C0006142 |
| Disease | Adrenal gland hypofunction | 2.43e-04 | 4 | 189 | 2 | C0001623 | |
| Disease | Ullrich congenital muscular dystrophy | 2.43e-04 | 4 | 189 | 2 | cv:C4551860 | |
| Disease | De Toni-Debre-Fanconi Syndrome | 2.43e-04 | 4 | 189 | 2 | C1857395 | |
| Disease | Bethlem myopathy | 2.43e-04 | 4 | 189 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.43e-04 | 4 | 189 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.43e-04 | 4 | 189 | 2 | C0410179 | |
| Disease | Fanconi-Bickel Syndrome | 2.43e-04 | 4 | 189 | 2 | C3495427 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.43e-04 | 4 | 189 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Adult Fanconi syndrome | 2.43e-04 | 4 | 189 | 2 | C0341703 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.43e-04 | 4 | 189 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.76e-04 | 49 | 189 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 3.27e-04 | 265 | 189 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.35e-04 | 266 | 189 | 8 | C0242379 | |
| Disease | Fanconi Syndrome | 4.03e-04 | 5 | 189 | 2 | C0015624 | |
| Disease | acute pancreatitis (biomarker_via_orthology) | 4.03e-04 | 5 | 189 | 2 | DOID:2913 (biomarker_via_orthology) | |
| Disease | DiGeorge syndrome (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | Arteriosclerosis | 4.03e-04 | 5 | 189 | 2 | C0003850 | |
| Disease | cortical surface area measurement | CCDC91 PDE3A RGPD1 DYSF STN1 EVI5 SERPINA1 PMPCA TLN2 SDR16C5 PLXNA2 WNT7A DUT RPSA CHD7 EBF1 CELF2 RASGEF1C ROBO1 ARHGAP28 | 4.21e-04 | 1345 | 189 | 20 | EFO_0010736 |
| Disease | HIV Infections | 5.39e-04 | 103 | 189 | 5 | C0019693 | |
| Disease | HIV Coinfection | 5.39e-04 | 103 | 189 | 5 | C4505456 | |
| Disease | glucagon measurement, glucose tolerance test | 6.02e-04 | 6 | 189 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 6.02e-04 | 6 | 189 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | blood manganese measurement | 6.75e-04 | 27 | 189 | 3 | EFO_0007581 | |
| Disease | anterior thigh muscle fat infiltration measurement | 7.53e-04 | 28 | 189 | 3 | EFO_0020936 | |
| Disease | Shwachman-Diamond syndrome (implicated_via_orthology) | 8.39e-04 | 7 | 189 | 2 | DOID:0060479 (implicated_via_orthology) | |
| Disease | peripheral neuropathy | 8.39e-04 | 7 | 189 | 2 | EFO_0003100 | |
| Disease | histidine measurement | 8.62e-04 | 66 | 189 | 4 | EFO_0009769 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 9.24e-04 | 30 | 189 | 3 | C1868672 | |
| Disease | lung adenocarcinoma | 9.26e-04 | 174 | 189 | 6 | EFO_0000571 | |
| Disease | hyperuricemia | 1.22e-03 | 33 | 189 | 3 | EFO_0009104 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.46e-03 | 35 | 189 | 3 | EFO_0020934 | |
| Disease | facial emotion recognition measurement | 1.46e-03 | 35 | 189 | 3 | EFO_0008329 | |
| Disease | peak expiratory flow | CCDC91 PDE3A DYSF STN1 SERPINA1 DST KDR WNT7A SYAP1 RASGEF1C | 1.47e-03 | 498 | 189 | 10 | EFO_0009718 |
| Disease | mean arterial pressure | 1.49e-03 | 499 | 189 | 10 | EFO_0006340 | |
| Disease | Autistic Disorder | 1.53e-03 | 261 | 189 | 7 | C0004352 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.66e-03 | 195 | 189 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Schizophrenia | CHRNA3 NRXN3 PIK3CB PI4KA KDR GNAS PLXNA2 GRIN2A PPP3R1 CELF2 TET1 UHMK1 APOL4 CSMD1 | 1.74e-03 | 883 | 189 | 14 | C0036341 |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.76e-03 | 80 | 189 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.78e-03 | 10 | 189 | 2 | GO_0097327, GO_0097328 | |
| Disease | abdominal obesity-metabolic syndrome (implicated_via_orthology) | 1.78e-03 | 10 | 189 | 2 | DOID:0060611 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease, chronic bronchitis | 1.78e-03 | 10 | 189 | 2 | EFO_0000341, EFO_0006505 | |
| Disease | Colorectal Carcinoma | KL PTPRD PTPRS PDILT KDR GNAS APOB GRIN2A NXN HPS3 GUCY2C MMRN2 | 1.99e-03 | 702 | 189 | 12 | C0009402 |
| Disease | aspartate aminotransferase measurement | PDE3A STN1 SERPINA1 PTPRD CACNA1S ANPEP BAG3 OCRL LCT SLC2A2 WDR91 CELF2 ROBO1 CSMD1 | 2.16e-03 | 904 | 189 | 14 | EFO_0004736 |
| Disease | kidney disease (implicated_via_orthology) | 2.31e-03 | 41 | 189 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.47e-03 | 447 | 189 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | emphysema imaging measurement | 2.55e-03 | 146 | 189 | 5 | EFO_0007626 | |
| Disease | Pathological accumulation of air in tissues | 2.58e-03 | 12 | 189 | 2 | C0013990 | |
| Disease | level of Ceramide (d42:2) in blood serum | 2.58e-03 | 12 | 189 | 2 | OBA_2045186 | |
| Disease | potassium measurement | 3.01e-03 | 45 | 189 | 3 | EFO_0009283 | |
| Disease | glucose measurement | 3.25e-03 | 380 | 189 | 8 | EFO_0004468 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 3.41e-03 | 47 | 189 | 3 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | white matter hyperintensity measurement | 3.45e-03 | 302 | 189 | 7 | EFO_0005665 | |
| Disease | Myopia | 3.52e-03 | 385 | 189 | 8 | HP_0000545 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.53e-03 | 14 | 189 | 2 | cv:C2931907 | |
| Disease | tumor necrosis factor-alpha measurement | 3.84e-03 | 49 | 189 | 3 | EFO_0004684 | |
| Disease | pancreatic cancer (is_marker_for) | 4.11e-03 | 101 | 189 | 4 | DOID:1793 (is_marker_for) | |
| Disease | chronic kidney disease | 4.18e-03 | 235 | 189 | 6 | EFO_0003884 | |
| Disease | Alzheimer disease | 4.22e-03 | 485 | 189 | 9 | MONDO_0004975 | |
| Disease | diastolic blood pressure, body mass index | 4.62e-03 | 16 | 189 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | fourth ventricle volume measurement | 4.62e-03 | 16 | 189 | 2 | EFO_0010303 | |
| Disease | Abnormal behavior | 4.62e-03 | 16 | 189 | 2 | C0233514 | |
| Disease | monoclonal gammopathy | 4.79e-03 | 53 | 189 | 3 | EFO_0000203 | |
| Disease | Dupuytren Contracture | 5.21e-03 | 108 | 189 | 4 | EFO_0004229 | |
| Disease | response to radiation, Urinary retention | 5.21e-03 | 17 | 189 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 5.21e-03 | 17 | 189 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 5.21e-03 | 17 | 189 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | pancreatic carcinoma | 5.37e-03 | 174 | 189 | 5 | EFO_0002618 | |
| Disease | peptide measurement | 5.38e-03 | 109 | 189 | 4 | EFO_0010520 | |
| Disease | mitochondrial DNA measurement | 5.39e-03 | 328 | 189 | 7 | EFO_0006312 | |
| Disease | Tachycardia | 5.84e-03 | 18 | 189 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 5.84e-03 | 18 | 189 | 2 | C0080203 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGFEAAKEKALQFLE | 121 | P40227 | |
| FAENKEIQKLAEQFV | 91 | O95994 | |
| FEGKKDVTQIFNNIL | 91 | Q9H9S4 | |
| EVLQGLDFFGNKKSV | 41 | Q9Y2R4 | |
| NEITFDKIFNQKIGF | 51 | P35626 | |
| FGNVISAKVFIDKQT | 446 | O95319 | |
| NFDENKVDVTQFKAT | 161 | Q96N23 | |
| VENTDEAQKKFGNVK | 411 | Q9NP61 | |
| LEEFKEAFAGAVKAN | 891 | Q8IVF6 | |
| QIKGQADIFVSKFEN | 3416 | Q96PZ7 | |
| NAVGDFQVDDKTKAL | 126 | P32297 | |
| AGQFQEKKRFTEEVI | 26 | Q9BPW4 | |
| AFTVNFGDTEEAKKQ | 166 | P01009 | |
| EEEKFFLNAKGQKET | 41 | Q9Y673 | |
| NFQLFEKGDVNGEKE | 131 | P22352 | |
| DFEGKKDVAQIFNNI | 91 | Q9Y376 | |
| QQLEQFKKDNEETGF | 916 | P15144 | |
| DFKEFIEGVSQFSVK | 71 | P63098 | |
| LSKQEESKAAFGEEV | 206 | O00273 | |
| GLKSAVDVVFQAQKE | 86 | Q0PNE2 | |
| NKAGFAVNFFKEVDE | 536 | P13497 | |
| EFGDESKLQDKIFIT | 486 | Q8ND07 | |
| DGEISFQEFLTAAKK | 61 | Q9NZT1 | |
| AKQGQNKFLSEIEDE | 861 | Q9P2D1 | |
| FNGDVKTDVNKIEEF | 236 | Q9NZA1 | |
| ELISIFQEAKQFGQK | 521 | Q6P1M9 | |
| KENAEKFADTVQGEV | 171 | Q14894 | |
| KVASVAENKGLFEEA | 611 | Q8N1F7 | |
| FVTGDKFDENAQVGK | 286 | P07205 | |
| EVFTNQEVKEKFEGL | 21 | Q14206 | |
| KTGENVEDAFLEAAK | 156 | P61106 | |
| EVTFQEGKEFADSQK | 141 | Q9H0T7 | |
| FIGFKSEEEAQKAQK | 46 | Q9Y4C8 | |
| AESVFVETFVQKQKG | 201 | Q8N3Y7 | |
| KAQDFVKKFNQVLGD | 551 | Q29RF7 | |
| GFKVVLRQDKEFQDI | 221 | P25092 | |
| FKFQDDNVEGDKVSK | 1731 | Q92621 | |
| TAAENEFVGLKKDVD | 281 | Q01546 | |
| SIDVEGKIFQAAKDA | 636 | P33897 | |
| KEGEFVAQFKFTVLL | 311 | Q9UQ80 | |
| FFSQEKDLDGKIQNA | 911 | Q5HY64 | |
| RFQNVAKEGVKFDDS | 226 | Q58FF3 | |
| QKEDELTAVNVKQGF | 31 | Q86YW9 | |
| GDTLEAKEFAKQFLE | 946 | O75420 | |
| IEQFFTKFVDEGKAT | 66 | Q96L50 | |
| FQELGAKFEAKVQEN | 286 | Q9H8L6 | |
| AEVVKNTENFLKENG | 3701 | Q03001 | |
| QQVDAGLTFNKKEFE | 66 | Q13480 | |
| NVKENTIKFEGDFDF | 241 | Q9BX40 | |
| TDQAFGELEKNSDKF | 956 | Q15751 | |
| IFENVGFTKDVGNIK | 76 | P47224 | |
| KTDFVQKLAGVFGEN | 256 | Q8ND23 | |
| TQTFAKEEGIKVFED | 6671 | Q5CZC0 | |
| EEILEKAFSQFGKLE | 351 | O60506 | |
| QDDVLFAIFSKGQKQ | 331 | O75051 | |
| KGTLQKFVDDLFQVI | 1926 | O43157 | |
| KKTVTVEFFLVGQDN | 146 | Q8NDH3 | |
| FVAKFNGKVNDDVGI | 916 | Q14432 | |
| FKEKDSLGQEVLFNV | 216 | O60447 | |
| ETKGKSFEEIAAEFQ | 486 | P11168 | |
| KNTKVDFFAVELLDG | 501 | Q9Y4C0 | |
| VFLDQSQVKADGFQK | 61 | Q9NPC7 | |
| EQKFGLFSAEIKEAD | 1261 | P42356 | |
| LKQVDNGEKFEFSGL | 471 | P55160 | |
| FEAINKDQVLTIGFD | 301 | P09848 | |
| KSFTGNFVIDENILK | 236 | Q6YN16 | |
| KVFLGNVETFIKQID | 761 | O95163 | |
| EEELKFFLQKFESGA | 61 | P0CE71 | |
| KTLVGKNFEQVAFDE | 391 | Q13087 | |
| FEGEVTKENLLDFIK | 216 | P07237 | |
| VLVGKNFEDVAFDEK | 371 | P07237 | |
| FVTADKFDENAKTGQ | 286 | P00558 | |
| NVGVVLFNFGKEKFE | 196 | P33316 | |
| QNEIGKIFEKSFVNL | 466 | Q06190 | |
| FIDFIGQVHKTKEQF | 1856 | Q13332 | |
| VIQKFFEFGSLEQKL | 901 | Q14671 | |
| EVLVFQLSKGNFADK | 21 | Q8NB91 | |
| KFREFFVTVEAQDKG | 541 | Q9Y5I4 | |
| STIFVAFKGNIDDKD | 46 | Q14686 | |
| EEELKFFLQKFESGA | 61 | P0CE72 | |
| NELFGKFDQIAKENE | 316 | Q08462 | |
| VDSKNIFNFKVSQEG | 1721 | P04114 | |
| GDFEVAEKINAFRAK | 2326 | P04114 | |
| KGESKLEVLNFDFQA | 2796 | P04114 | |
| VVIKVNGFEFSAHKN | 41 | Q6JEL2 | |
| QAFKELQGLEDFIAK | 236 | Q16696 | |
| EQATENFLEKGDKIA | 66 | P35221 | |
| FERAAEKGNFEAAVK | 91 | P41002 | |
| IGLQNFEIAKDFVVK | 626 | P12109 | |
| KIKTEGNFEQANEEL | 1476 | Q13698 | |
| KGFLKEKEQEAISFQ | 171 | Q7Z6B0 | |
| FSANIDFKEEKQAGV | 331 | Q5T197 | |
| SSGVFELKLQEFVNK | 21 | O00548 | |
| EFKQAIQASIKEFGF | 161 | Q86SF2 | |
| KGNVKEFTETAAIFE | 301 | P49326 | |
| QIGVVQFSDKTKEEF | 666 | A8TX70 | |
| VFVAQKGFESKVDAI | 1851 | P12111 | |
| GIFETKFQVDKVNFH | 206 | P63092 | |
| RTAFVGFVEKEKEAN | 86 | Q9UH73 | |
| KLVTVEKQDNETFGF | 76 | O60759 | |
| TVDEGDKVQFEEFAK | 646 | Q8IY85 | |
| GKQDFREDQDAAFFK | 46 | Q00978 | |
| KAFQTFLGKADVSQE | 271 | Q9NRM0 | |
| EDEKKLIQGTFDFLA | 791 | Q9UEF7 | |
| FGVVKEEIFDDNAKL | 56 | O14640 | |
| DTDGKGILNKQEFFV | 61 | P42566 | |
| NFKVNKKITFTDEGE | 681 | Q13206 | |
| IKGQDTIFKNAEFLV | 411 | Q8NDH2 | |
| LNFDEFAVSKDGIEK | 721 | Q9Y613 | |
| KGFKFDETEQALANE | 776 | Q7L014 | |
| FGVVKEEIFDDNAKL | 56 | P54792 | |
| SFQLFEKGDVNGEKE | 131 | O75715 | |
| SFQLFEKGDVNGEKE | 131 | P59796 | |
| AVKFDEQKLVTGSFD | 191 | Q9UKT8 | |
| KVQGLEQAVDNFEGK | 431 | O95817 | |
| TFNQAAKGVNKEFTV | 216 | Q96EY1 | |
| KESKRQFIFDVVNEG | 4166 | Q92736 | |
| QFIFDVVNEGGEKEK | 4171 | Q92736 | |
| SVDEKEFNQFAEGKL | 861 | O75923 | |
| TKGKEIDFDDVAAIN | 51 | Q99661 | |
| IDVDFNVGKIQKVKF | 406 | P54317 | |
| NQKFFQDLKEETGID | 271 | O94851 | |
| GKKVSNQRFEVIEFD | 61 | P23468 | |
| GKQDFLKEVVETFAN | 356 | P0DJD0 | |
| KIEAINKEGTFTVQF | 106 | A8MW92 | |
| EAKKKIEQQGGFTFE | 1006 | O15397 | |
| DFVGKDEEFTLKLIN | 366 | O14926 | |
| QLVGKNFNVVVFDKE | 391 | Q8N807 | |
| IFENIGNNIKKETVF | 1341 | Q5JY77 | |
| GNNIKKETVFSDDDF | 1346 | Q5JY77 | |
| AAAEKAVTKEEFQGE | 216 | P08865 | |
| KQFAKFVVDLSDQVA | 116 | P35998 | |
| FATVDGQEKFETKVT | 56 | Q10713 | |
| EGNKTFIDNLVNFEK | 936 | Q8WZA2 | |
| FKAVDKEQLGTITFE | 1561 | Q9C093 | |
| EKGLVFQKDDGFDNL | 276 | Q9H668 | |
| IASEGVEKFKNENFE | 171 | P61011 | |
| QVKSIVFDGAKAFVE | 801 | Q8NDG6 | |
| NNKIGIEEADSFFKV | 751 | Q969F9 | |
| KIKEAGQNFEIIFVS | 221 | Q6DKJ4 | |
| FLEANKIGFEEKDIA | 26 | O75368 | |
| QFTEEKFGQAEKTEL | 21 | Q9NR46 | |
| EDSQLVAGVAFKKTF | 206 | Q99832 | |
| IGDFQKEQKKFVEEQ | 101 | Q96A49 | |
| AALTFFLGKDEDEKQ | 216 | Q9NVU7 | |
| DQLLEFFKQVGEVKF | 81 | Q8WXA9 | |
| NNKVFGEDSVGVIFK | 791 | P42338 | |
| LGKFTFDVEKSEIQT | 371 | Q9NPE6 | |
| QRTQKKAFVDFNEGE | 456 | Q01968 | |
| KSELENIKGIFVFGN | 431 | O95470 | |
| TVVLQKKDNEGFGFV | 626 | Q9UPX8 | |
| KFNIEEFGKTLENNS | 776 | Q8NFU7 | |
| NIIQVKKTDFEVFDA | 151 | Q9Y478 | |
| VEAANKGDVEAFAKA | 366 | Q16186 | |
| KLAEFGAEFKNIETN | 241 | O75503 | |
| KEEFVLAAQKFGQVT | 251 | Q9UJS0 | |
| VDEFLDKFLSAGVKQ | 66 | Q9NRB3 | |
| VGEFLQFVQLDKEAS | 16 | Q86XI2 | |
| LNVIFTKFDEVQKSG | 216 | Q7Z460 | |
| QDFASTVEALEEGKK | 1381 | P35749 | |
| FIGLFETQEKEFVTK | 546 | Q7RTR0 | |
| TFQQFKEAVKELGQK | 66 | P59282 | |
| KGDVQQAIKNLFSEE | 1481 | A4UGR9 | |
| VVGFLEANKIDFKEL | 86 | P55822 | |
| KQFQAFGDLFDEAIK | 321 | Q7Z392 | |
| FKKESDDFLGQTIVE | 1301 | Q8NB66 | |
| KAGEDEKQAFLQVFV | 286 | O15394 | |
| EDFIKKQIEEFNIGK | 71 | P82933 | |
| DAKFVLIVEKDATFQ | 216 | Q9Y5K1 | |
| VLQKFFEKVEESGLE | 401 | Q9P2N2 | |
| NFEKFLELAKQVGEF | 391 | Q8N431 | |
| GTFIKESVQKNEFIS | 626 | Q92800 | |
| KQQETSAGEEFFVLK | 76 | O75830 | |
| GNKEFFQSAIKLVDF | 126 | O75830 | |
| FQSAIKLVDFQDAKA | 131 | O75830 | |
| LNIFNQIAEFEKEKG | 751 | Q96N46 | |
| NEFQGADSEIKFAKT | 756 | Q9Y6N7 | |
| GVKEVDDFFEQEKNF | 201 | Q9Y5X3 | |
| NNANVLFKTKFVDGV | 1151 | O95347 | |
| IQFSDGNEFAVDKSK | 26 | Q9Y2C9 | |
| EQDAASLKDVFKGFD | 1281 | Q9UPT8 | |
| GFAKVFVDAREIKQN | 161 | O00755 | |
| QKAAFGKADDDDVVV | 2476 | Q9Y4G6 | |
| KKEAGINDVSNFETF | 1406 | Q01118 | |
| QNELFGKIQAEFEKK | 206 | Q12874 | |
| EKNFKEVFAIQETNG | 851 | Q13342 | |
| AKVEAFFIIEGAQEK | 746 | P35968 | |
| QKNEFKAAFDIFVLG | 16 | P63316 | |
| DKAQEFFAKQATELQ | 106 | A4D1P6 | |
| KGFIDDDKVTFEVFV | 181 | Q93009 | |
| AQAEGKFAQKEETLA | 1631 | Q6ZQQ6 | |
| IDFGLSFKEGNQDVK | 176 | Q8TAS1 | |
| DIQELFAEFGTLKKA | 121 | Q86V81 | |
| GKSFINSETIEDFQK | 451 | Q9C0D4 | |
| DVKDGFENVATELAK | 656 | Q9C099 | |
| ENIREGQKDFVFVKF | 21 | A6PVS8 | |
| VIGFIDKNKDTLFQD | 516 | O94832 | |
| QFVGKREKIDFADTV | 756 | Q12965 | |
| AAAEKFKVQGEAVSN | 2001 | E9PAV3 | |
| QLAAAEKFKVQGEAV | 136 | Q13765 | |
| ISDKVISQKEGDFFF | 1846 | Q6PIF6 | |
| EEFVDQVTGLSDKKF | 656 | Q12879 |